Mortality prediction in Mexican older COVID-19 patients using the Charlson comorbidity index: a case- control study from a reconverted COVID-19 hospital

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objectives : We aim to describe the predisposing factors for COVID-19 pneumonia and in-hospital death as an outcome of COVID-19 in a Mexican aged cohort of northeast Mexico. The use of CCI to predict mortality in this population will also be investigated. Study design: A case-control study was performed in a total of 356 records from patients of 60 years old and above. Records were collected from November 2019 to August 2022 from a reconverted COVID-19 hospital located in Nuevo León, Mexico, from which 332 records were included in the study. Main outcome measures : Stepwise multivariate logistical regression models were used to determine COVID-19 pneumonia or outcome odds ratio (OR) and 95% Confidence Interval (CI). Results : Age, dyspnea, sO 2 /FiO 2, and body mass index (BMI) were associated with COVID-19 pneumonia whereas respiratory frequency, BMI, sO 2 /FiO 2 (Saturation of oxygen/Fraction of inspired oxygen ratio) and CCI were associated with death due to COVID-19. An increased hazard ratio of mortality of 2.1 (p < 0.001) was observed in patients with a CCI below 3. Conclusions : CCI revealed to be not appropriate to predict mortality in geriatric Mexican population, a deeper analysis is required when using CCI in such population.

Article activity feed